The role of PET in the first-line treatment of the most common subtypes of non-Hodgkin lymphoma.


Journal

The Lancet. Haematology
ISSN: 2352-3026
Titre abrégé: Lancet Haematol
Pays: England
ID NLM: 101643584

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 26 05 2020
revised: 12 10 2020
accepted: 02 11 2020
pubmed: 29 12 2020
medline: 5 1 2021
entrez: 28 12 2020
Statut: ppublish

Résumé

This Review focuses on the use of

Identifiants

pubmed: 33357487
pii: S2352-3026(20)30365-3
doi: 10.1016/S2352-3026(20)30365-3
pii:
doi:

Substances chimiques

Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e80-e93

Subventions

Organisme : Department of Health
ID : RP-2016-07-001
Pays : United Kingdom

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Sally F Barrington (SF)

King's College London and Guy's and St Thomas' PET Centre, School of Biomedical Engineering and Imaging Sciences, King's College London, King's Health Partners, London, UK. Electronic address: sally.barrington@kcl.ac.uk.

Judith Trotman (J)

Haematology Department, Concord Repatriation General, Hospital, University of Sydney, Sydney, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH